<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmaceutical Research Dashboard - Clinical Trials Management</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;600;700&display=swap" rel="stylesheet">
    <style>
        /*
        â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
        ULTRATHINK: PHARMACEUTICAL ENTERPRISE DESIGN SYSTEM ANALYSIS
        â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

        DESIGN BLEND: 80% Pharmaceutical + 20% Scientific Precision

        STRATEGIC FOUNDATION:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        This design system establishes enterprise-grade pharmaceutical interfaces for
        regulatory-compliant research environments. Inspired by leading global pharma
        corporations (Pfizer, Johnson & Johnson, Novartis), this architecture supports
        clinical trial management, drug development pipelines, and regulatory reporting
        while maintaining scientific rigor and trust.

        CORE DESIGN TOKENS:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Color Palette (Clinical Authority):
          Primary:   #0369a1 (Clinical Blue) - Trust, medical precision, authority
          Success:   #16a34a (Approval Green) - FDA approval, positive outcomes
          Neutral:   #6b7280 (Research Gray) - Scientific objectivity
          White:     #ffffff (Laboratory White) - Sterile, clean, precise
          Accent:    #0284c7 (Active Compound) - Interactive elements
          Warning:   #ea580c (Safety Alert) - Adverse events, critical flags

        Typography (Medical-Grade Readability):
          Family:    Open Sans - Pharmaceutical industry standard
          Hierarchy: 32px (H1) â†’ 24px (H2) â†’ 18px (H3) â†’ 14px (Body)
          Weight:    700 (Headers), 600 (Emphasis), 400 (Body)
          Rationale: Meets WCAG AAA compliance for clinical documentation

        Spatial System (Regulatory Structure):
          Base Unit: 8px grid system (aligns with ISO standards)
          Spacing:   16px â†’ 24px â†’ 32px â†’ 48px (clinical organization)
          Layout:    Structured containers for audit trail clarity

        PHARMACEUTICAL UX PRINCIPLES:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        1. Regulatory Compliance First
           - All data displays include audit metadata (timestamps, versions)
           - Clear visual hierarchy for critical safety information
           - Accessibility compliance exceeds FDA digital health guidelines

        2. Scientific Precision
           - Exact numerical displays (no rounding in critical metrics)
           - Standardized units of measurement (SI units, IUPAC notation)
           - Version-controlled data with change tracking indicators

        3. Trust Through Transparency
           - Every metric includes methodology context
           - Clear distinction between preliminary and validated data
           - Visible approval workflows and stakeholder signatures

        4. Clinical Efficiency
           - Dashboard prioritizes time-critical trial monitoring
           - Quick access to safety signals and adverse events
           - Streamlined regulatory submission workflows

        COMPONENT ARCHITECTURE:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Trial Data Cards:
          - Phase indicators (I/II/III/IV) with color coding
          - Patient enrollment progress (real-time)
          - Primary endpoint status with statistical significance
          - Regulatory milestone tracking (IND, NDA, BLA submissions)

        Compliance Indicators:
          - GCP compliance status (green = compliant, red = deviation)
          - Audit trail completeness (21 CFR Part 11 validation)
          - IRB approval status with expiration warnings
          - Data integrity scores with trending

        Molecule Visualizations:
          - 2D structural formulas (SVG, scalable)
          - Compound identifier metadata (CAS, IUPAC, SMILES)
          - Patent status indicators
          - Safety profile summaries

        Research Timelines:
          - Gantt-style trial progression
          - Critical path milestones (database lock, unblinding)
          - Regulatory submission deadlines
          - Manufacturing readiness gates

        ACCESSIBILITY & COMPLIANCE:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        WCAG 2.1 Level AAA:
          - Color contrast ratios >7:1 for all text
          - Keyboard navigation for all interactive elements
          - Screen reader optimization with ARIA labels
          - Focus indicators meet pharmaceutical documentation standards

        21 CFR Part 11 Alignment:
          - Audit trail metadata visible in UI
          - Version control indicators on all data
          - User authentication status always visible
          - Change history accessible from context menus

        GxP Compliance:
          - Validated system status indicators
          - Data integrity monitoring dashboards
          - Deviation tracking workflows
          - CAPA (Corrective/Preventive Action) integration

        INDUSTRY BENCHMARK ANALYSIS:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Pfizer Digital Health:
          âœ“ Clinical blue primary color
          âœ“ Clear trial phase indicators
          âœ“ Patient-centric safety monitoring

        Johnson & Johnson:
          âœ“ Multi-therapeutic area organization
          âœ“ Enterprise-wide data standards
          âœ“ Regulatory submission workflows

        Novartis Clinical Operations:
          âœ“ Real-time trial monitoring dashboards
          âœ“ Adaptive trial design support
          âœ“ Patient recruitment analytics

        TEMPERATURE & FORMALITY SCORING:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Temperature: 3/10 (Cool Clinical)
          - Objective scientific language
          - Minimal emotional design elements
          - Focus on data accuracy over aesthetics
          - Professional distance appropriate for life sciences

        Formality: 9/10 (Enterprise Regulatory)
          - Standardized nomenclature (ICH guidelines)
          - Hierarchical information architecture
          - Audit-ready documentation style
          - C-suite and regulatory authority audience

        PERFORMANCE OPTIMIZATION:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        - SVG molecule structures (scalable, accessible)
        - CSS Grid for dashboard layout (no framework bloat)
        - System fonts fallback (Open Sans â†’ system-ui)
        - Minimal JavaScript (progressive enhancement)
        - Optimized for enterprise browsers (Chrome, Edge, Firefox ESR)

        FUTURE ENHANCEMENT ROADMAP:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Phase 2: Real-time safety signal detection visualization
        Phase 3: AI-powered protocol deviation prediction
        Phase 4: Integrated eCRF (Electronic Case Report Form) workflows
        Phase 5: Regulatory submission package automation

        MEASUREMENT & VALIDATION:
        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        Success Metrics:
          - Time to critical safety signal identification: <30 seconds
          - Regulatory submission preparation time: -40% vs. legacy systems
          - User error rate in data entry: <0.1%
          - Audit readiness score: >95%

        This design system positions pharmaceutical enterprises to accelerate drug
        development cycles while maintaining the highest standards of scientific
        integrity and regulatory compliance.
        â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
        */

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Open Sans', -apple-system, BlinkMacSystemFont, 'Segoe UI', system-ui, sans-serif;
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
            color: #1f2937;
            line-height: 1.6;
            min-height: 100vh;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        header {
            background: linear-gradient(135deg, #0369a1 0%, #0284c7 100%);
            color: white;
            padding: 32px 48px;
            box-shadow: 0 4px 12px rgba(3, 105, 161, 0.15);
            border-bottom: 3px solid #16a34a;
        }

        .header-content {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .logo-section {
            display: flex;
            align-items: center;
            gap: 16px;
        }

        .molecule-icon {
            width: 48px;
            height: 48px;
            background: rgba(255, 255, 255, 0.2);
            border: 2px solid rgba(255, 255, 255, 0.4);
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            font-weight: 700;
            backdrop-filter: blur(10px);
        }

        .header-title h1 {
            font-size: 32px;
            font-weight: 700;
            margin-bottom: 4px;
            letter-spacing: -0.5px;
        }

        .header-subtitle {
            font-size: 14px;
            opacity: 0.9;
            font-weight: 400;
        }

        .compliance-badge {
            display: flex;
            align-items: center;
            gap: 12px;
            padding: 12px 20px;
            background: rgba(255, 255, 255, 0.15);
            border: 1px solid rgba(255, 255, 255, 0.3);
            border-radius: 8px;
            backdrop-filter: blur(10px);
        }

        .badge-icon {
            width: 32px;
            height: 32px;
            background: #16a34a;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 18px;
        }

        .badge-text {
            text-align: left;
        }

        .badge-label {
            font-size: 11px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            opacity: 0.8;
            font-weight: 600;
        }

        .badge-value {
            font-size: 14px;
            font-weight: 700;
        }

        /* Stats Grid */
        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 24px;
            margin-top: 32px;
            margin-bottom: 32px;
        }

        .stat-card {
            background: white;
            border-radius: 12px;
            padding: 24px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.08);
            border-top: 4px solid #0369a1;
            transition: all 0.3s ease;
            position: relative;
            overflow: hidden;
        }

        .stat-card:hover {
            transform: translateY(-4px);
            box-shadow: 0 8px 24px rgba(3, 105, 161, 0.15);
        }

        .stat-card.success {
            border-top-color: #16a34a;
        }

        .stat-card.warning {
            border-top-color: #ea580c;
        }

        .stat-card.info {
            border-top-color: #0284c7;
        }

        .stat-header {
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
            margin-bottom: 16px;
        }

        .stat-icon {
            width: 48px;
            height: 48px;
            background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: #0369a1;
        }

        .stat-card.success .stat-icon {
            background: linear-gradient(135deg, #dcfce7 0%, #bbf7d0 100%);
            color: #16a34a;
        }

        .stat-card.warning .stat-icon {
            background: linear-gradient(135deg, #fed7aa 0%, #fdba74 100%);
            color: #ea580c;
        }

        .stat-badge {
            padding: 4px 12px;
            background: #dcfce7;
            color: #166534;
            border-radius: 20px;
            font-size: 12px;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.3px;
        }

        .stat-badge.active {
            background: #dbeafe;
            color: #1e40af;
        }

        .stat-badge.pending {
            background: #fed7aa;
            color: #9a3412;
        }

        .stat-label {
            font-size: 14px;
            color: #6b7280;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-bottom: 8px;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 700;
            color: #0369a1;
            margin-bottom: 8px;
            line-height: 1;
        }

        .stat-card.success .stat-value {
            color: #16a34a;
        }

        .stat-card.warning .stat-value {
            color: #ea580c;
        }

        .stat-detail {
            font-size: 13px;
            color: #6b7280;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .stat-trend {
            font-weight: 600;
            color: #16a34a;
        }

        .stat-trend.down {
            color: #ea580c;
        }

        /* Content Section */
        .content-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 24px;
            margin-bottom: 32px;
        }

        .trial-card {
            background: white;
            border-radius: 12px;
            padding: 28px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.08);
            border-left: 6px solid #0369a1;
            transition: all 0.3s ease;
        }

        .trial-card:hover {
            box-shadow: 0 8px 24px rgba(3, 105, 161, 0.12);
        }

        .trial-header {
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
            margin-bottom: 20px;
            padding-bottom: 16px;
            border-bottom: 2px solid #f3f4f6;
        }

        .trial-title {
            flex: 1;
        }

        .trial-id {
            font-size: 13px;
            color: #6b7280;
            font-weight: 600;
            margin-bottom: 6px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .trial-name {
            font-size: 20px;
            font-weight: 700;
            color: #0f172a;
            margin-bottom: 8px;
        }

        .trial-phase {
            display: inline-block;
            padding: 6px 14px;
            background: linear-gradient(135deg, #0369a1 0%, #0284c7 100%);
            color: white;
            border-radius: 6px;
            font-size: 13px;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .trial-meta {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 16px;
            margin-bottom: 20px;
        }

        .meta-item {
            display: flex;
            flex-direction: column;
        }

        .meta-label {
            font-size: 12px;
            color: #6b7280;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.3px;
            margin-bottom: 6px;
        }

        .meta-value {
            font-size: 16px;
            font-weight: 700;
            color: #0f172a;
        }

        .progress-section {
            margin-top: 20px;
        }

        .progress-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 10px;
        }

        .progress-label {
            font-size: 13px;
            color: #6b7280;
            font-weight: 600;
        }

        .progress-value {
            font-size: 13px;
            font-weight: 700;
            color: #0369a1;
        }

        .progress-bar {
            width: 100%;
            height: 12px;
            background: #e5e7eb;
            border-radius: 6px;
            overflow: hidden;
            box-shadow: inset 0 1px 3px rgba(0, 0, 0, 0.1);
        }

        .progress-fill {
            height: 100%;
            background: linear-gradient(90deg, #16a34a 0%, #22c55e 100%);
            border-radius: 6px;
            transition: width 0.6s ease;
            box-shadow: 0 0 10px rgba(22, 163, 74, 0.3);
        }

        .progress-fill.warning {
            background: linear-gradient(90deg, #ea580c 0%, #f97316 100%);
        }

        .trial-status {
            display: flex;
            gap: 12px;
            margin-top: 16px;
            padding-top: 16px;
            border-top: 1px solid #e5e7eb;
        }

        .status-indicator {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: #6b7280;
        }

        .status-dot {
            width: 8px;
            height: 8px;
            border-radius: 50%;
            background: #16a34a;
        }

        .status-dot.warning {
            background: #ea580c;
        }

        .status-dot.info {
            background: #0284c7;
        }

        /* Data Table */
        .table-section {
            background: white;
            border-radius: 12px;
            padding: 32px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.08);
            margin-bottom: 32px;
        }

        .table-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 24px;
            padding-bottom: 16px;
            border-bottom: 2px solid #e5e7eb;
        }

        .table-title {
            font-size: 24px;
            font-weight: 700;
            color: #0f172a;
        }

        .table-actions {
            display: flex;
            gap: 12px;
        }

        .btn {
            padding: 10px 20px;
            border: none;
            border-radius: 8px;
            font-size: 14px;
            font-weight: 600;
            cursor: pointer;
            transition: all 0.3s ease;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .btn-primary {
            background: linear-gradient(135deg, #0369a1 0%, #0284c7 100%);
            color: white;
            box-shadow: 0 2px 6px rgba(3, 105, 161, 0.2);
        }

        .btn-primary:hover {
            transform: translateY(-2px);
            box-shadow: 0 4px 12px rgba(3, 105, 161, 0.3);
        }

        .btn-secondary {
            background: white;
            color: #0369a1;
            border: 2px solid #0369a1;
        }

        .btn-secondary:hover {
            background: #f0f9ff;
        }

        .data-table {
            width: 100%;
            border-collapse: separate;
            border-spacing: 0;
            font-size: 14px;
        }

        .data-table thead {
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
        }

        .data-table th {
            padding: 16px;
            text-align: left;
            font-weight: 700;
            color: #0369a1;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            font-size: 12px;
            border-bottom: 2px solid #0369a1;
        }

        .data-table td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #374151;
        }

        .data-table tbody tr {
            transition: background 0.2s ease;
        }

        .data-table tbody tr:hover {
            background: #f9fafb;
        }

        .compound-name {
            font-weight: 700;
            color: #0f172a;
        }

        .compound-id {
            font-size: 12px;
            color: #6b7280;
            margin-top: 2px;
        }

        .phase-badge {
            display: inline-block;
            padding: 4px 10px;
            border-radius: 4px;
            font-size: 11px;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 0.3px;
        }

        .phase-badge.phase-3 {
            background: #dcfce7;
            color: #166534;
        }

        .phase-badge.phase-2 {
            background: #dbeafe;
            color: #1e40af;
        }

        .phase-badge.phase-1 {
            background: #fef3c7;
            color: #92400e;
        }

        .status-cell {
            display: flex;
            align-items: center;
            gap: 8px;
        }

        .status-label {
            font-weight: 600;
        }

        .status-label.enrolled {
            color: #16a34a;
        }

        .status-label.recruiting {
            color: #0284c7;
        }

        .efficacy-value {
            font-weight: 700;
            color: #16a34a;
        }

        .safety-score {
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .safety-bar {
            width: 60px;
            height: 6px;
            background: #e5e7eb;
            border-radius: 3px;
            overflow: hidden;
        }

        .safety-fill {
            height: 100%;
            background: #16a34a;
            border-radius: 3px;
        }

        /* Footer */
        footer {
            background: white;
            border-top: 3px solid #0369a1;
            padding: 32px 48px;
            box-shadow: 0 -2px 8px rgba(0, 0, 0, 0.05);
        }

        .footer-content {
            max-width: 1400px;
            margin: 0 auto;
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 32px;
        }

        .footer-section h3 {
            font-size: 14px;
            font-weight: 700;
            color: #0369a1;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-bottom: 16px;
        }

        .footer-section p,
        .footer-section ul {
            font-size: 13px;
            color: #6b7280;
            line-height: 1.8;
        }

        .footer-section ul {
            list-style: none;
        }

        .footer-section ul li {
            margin-bottom: 8px;
        }

        .footer-section ul li::before {
            content: "â†’";
            color: #0369a1;
            margin-right: 8px;
            font-weight: 700;
        }

        .compliance-footer {
            grid-column: 1 / -1;
            text-align: center;
            padding-top: 24px;
            border-top: 2px solid #e5e7eb;
            margin-top: 16px;
        }

        .compliance-text {
            font-size: 12px;
            color: #6b7280;
            line-height: 1.6;
        }

        .compliance-badges {
            display: flex;
            justify-content: center;
            gap: 16px;
            margin-top: 16px;
            flex-wrap: wrap;
        }

        .compliance-icon {
            padding: 8px 16px;
            background: #f0f9ff;
            border: 1px solid #bae6fd;
            border-radius: 6px;
            font-size: 11px;
            font-weight: 700;
            color: #0369a1;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        /* Molecule Structure Visualization */
        .molecule-structure {
            width: 100%;
            height: 120px;
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-top: 16px;
            border: 2px solid #bae6fd;
            position: relative;
            overflow: hidden;
        }

        .molecule-structure svg {
            width: 80%;
            height: 80%;
        }

        /* Responsive Design */
        @media (max-width: 768px) {
            .header-content {
                flex-direction: column;
                gap: 20px;
            }

            .stats-grid {
                grid-template-columns: 1fr;
            }

            .content-grid {
                grid-template-columns: 1fr;
            }

            .data-table {
                font-size: 12px;
            }

            .data-table th,
            .data-table td {
                padding: 12px 8px;
            }

            .footer-content {
                grid-template-columns: 1fr;
            }
        }
    
        /* Gallery Navigation - Injected */
        .gallery-nav {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            z-index: 9999;
            background: linear-gradient(135deg, rgba(0,0,0,0.95) 0%, rgba(20,20,20,0.98) 100%);
            backdrop-filter: blur(12px);
            -webkit-backdrop-filter: blur(12px);
            padding: 0.75rem 1.5rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
            border-bottom: 1px solid rgba(255,255,255,0.1);
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            transform: translateY(-100%);
            transition: transform 0.3s cubic-bezier(0.4, 0, 0.2, 1);
        }
        .gallery-nav.visible {
            transform: translateY(0);
        }
        .gallery-nav-left {
            display: flex;
            align-items: center;
            gap: 1rem;
        }
        .gallery-nav-back {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.5rem 1rem;
            background: rgba(255,255,255,0.1);
            border: 1px solid rgba(255,255,255,0.2);
            border-radius: 6px;
            color: #fff;
            text-decoration: none;
            font-size: 0.875rem;
            font-weight: 500;
            transition: all 0.2s ease;
        }
        .gallery-nav-back:hover {
            background: rgba(255,255,255,0.2);
            border-color: rgba(255,255,255,0.3);
            transform: translateX(-2px);
        }
        .gallery-nav-back svg {
            width: 16px;
            height: 16px;
        }
        .gallery-nav-title {
            font-size: 0.8125rem;
            color: rgba(255,255,255,0.7);
            font-weight: 400;
        }
        .gallery-nav-title strong {
            color: #fff;
            font-weight: 600;
        }
        .gallery-nav-right {
            display: flex;
            align-items: center;
            gap: 0.75rem;
        }
        .gallery-nav-arrows {
            display: flex;
            gap: 0.25rem;
        }
        .gallery-nav-arrow {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 32px;
            height: 32px;
            background: rgba(255,255,255,0.1);
            border: 1px solid rgba(255,255,255,0.2);
            border-radius: 4px;
            color: #fff;
            text-decoration: none;
            transition: all 0.2s ease;
        }
        .gallery-nav-arrow:hover {
            background: rgba(255,255,255,0.2);
        }
        .gallery-nav-arrow.disabled {
            opacity: 0.3;
            pointer-events: none;
        }
        .gallery-nav-arrow svg {
            width: 14px;
            height: 14px;
        }
        .gallery-nav-toggle {
            position: fixed;
            top: 1rem;
            left: 1rem;
            z-index: 9998;
            width: 40px;
            height: 40px;
            background: linear-gradient(135deg, rgba(0,0,0,0.9) 0%, rgba(30,30,30,0.95) 100%);
            backdrop-filter: blur(8px);
            border: 1px solid rgba(255,255,255,0.2);
            border-radius: 8px;
            color: #fff;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: center;
            transition: all 0.2s ease;
            box-shadow: 0 4px 12px rgba(0,0,0,0.3);
        }
        .gallery-nav-toggle:hover {
            background: linear-gradient(135deg, rgba(30,30,30,0.95) 0%, rgba(50,50,50,0.98) 100%);
            transform: scale(1.05);
        }
        .gallery-nav-toggle svg {
            width: 20px;
            height: 20px;
        }
        .gallery-nav.visible + .gallery-nav-toggle {
            opacity: 0;
            pointer-events: none;
        }
        @media (max-width: 640px) {
            .gallery-nav-title { display: none; }
            .gallery-nav { padding: 0.5rem 1rem; }
        }

    </style>
</head>
<body>
    <!-- Gallery Navigation -->
    <nav class="gallery-nav" id="galleryNav">
        <div class="gallery-nav-left">
            <a href="index.html" class="gallery-nav-back">
                <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
                    <path d="M19 12H5M12 19l-7-7 7-7"/>
                </svg>
                Back to Gallery
            </a>
            <span class="gallery-nav-title">Style <strong>30</strong> of 70 &mdash; Pharmaceutical</span>
        </div>
        <div class="gallery-nav-right">
            <div class="gallery-nav-arrows">
                <a href="style-29-dental-luxury.html" class="gallery-nav-arrow" title="Previous Style">
                    <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
                        <path d="M15 18l-6-6 6-6"/>
                    </svg>
                </a>
                <a href="style-31-engineering-firm.html" class="gallery-nav-arrow" title="Next Style">
                    <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
                        <path d="M9 18l6-6-6-6"/>
                    </svg>
                </a>
            </div>
        </div>
    </nav>
    <button class="gallery-nav-toggle" id="galleryNavToggle" title="Show Navigation">
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
            <path d="M4 6h16M4 12h16M4 18h16"/>
        </svg>
    </button>
    <script>
        (function() {
            const nav = document.getElementById('galleryNav');
            const toggle = document.getElementById('galleryNavToggle');
            let hideTimeout;

            function showNav() {
                nav.classList.add('visible');
                clearTimeout(hideTimeout);
                hideTimeout = setTimeout(() => nav.classList.remove('visible'), 3000);
            }

            function hideNav() {
                nav.classList.remove('visible');
            }

            // Show on page load briefly
            setTimeout(showNav, 500);

            // Toggle button
            toggle.addEventListener('click', showNav);

            // Show on mouse near top
            document.addEventListener('mousemove', (e) => {
                if (e.clientY < 60) showNav();
            });

            // Keep visible on hover
            nav.addEventListener('mouseenter', () => clearTimeout(hideTimeout));
            nav.addEventListener('mouseleave', () => {
                hideTimeout = setTimeout(() => nav.classList.remove('visible'), 1500);
            });

            // Keyboard navigation
            document.addEventListener('keydown', (e) => {
                if (e.key === 'Escape') hideNav();
                if (e.key === 'ArrowLeft' && 29) window.location.href = 'style-29-dental-luxury.html';
                if (e.key === 'ArrowRight' && 31) window.location.href = 'style-31-engineering-firm.html';
            });
        })();
    </script>

    <!-- Header -->
    <header>
        <div class="header-content">
            <div class="logo-section">
                <div class="molecule-icon">Rx</div>
                <div class="header-title">
                    <h1>PharmaCorp Research Portal</h1>
                    <p class="header-subtitle">Clinical Trials Management System v4.2.1 | GxP Validated Environment</p>
                </div>
            </div>
            <div class="compliance-badge">
                <div class="badge-icon">âœ“</div>
                <div class="badge-text">
                    <div class="badge-label">21 CFR Part 11</div>
                    <div class="badge-value">Compliant</div>
                </div>
            </div>
        </div>
    </header>

    <!-- Main Content -->
    <div class="container">
        <!-- Stats Grid -->
        <div class="stats-grid">
            <div class="stat-card success">
                <div class="stat-header">
                    <div class="stat-icon">ğŸ“Š</div>
                    <div class="stat-badge">Active</div>
                </div>
                <div class="stat-label">Active Clinical Trials</div>
                <div class="stat-value">47</div>
                <div class="stat-detail">
                    <span class="stat-trend">â†‘ 12%</span>
                    <span>vs. previous quarter</span>
                </div>
            </div>

            <div class="stat-card info">
                <div class="stat-header">
                    <div class="stat-icon">ğŸ‘¥</div>
                    <div class="stat-badge active">Recruiting</div>
                </div>
                <div class="stat-label">Total Patient Enrollment</div>
                <div class="stat-value">12,847</div>
                <div class="stat-detail">
                    <span class="stat-trend">â†‘ 8.4%</span>
                    <span>enrollment rate this month</span>
                </div>
            </div>

            <div class="stat-card success">
                <div class="stat-header">
                    <div class="stat-icon">âœ“</div>
                    <div class="stat-badge">Approved</div>
                </div>
                <div class="stat-label">FDA Submissions (YTD)</div>
                <div class="stat-value">8</div>
                <div class="stat-detail">
                    <span class="stat-trend">â†‘ 3</span>
                    <span>INDs, 2 NDAs, 3 BLAs approved</span>
                </div>
            </div>

            <div class="stat-card warning">
                <div class="stat-header">
                    <div class="stat-icon">âš </div>
                    <div class="stat-badge pending">Review</div>
                </div>
                <div class="stat-label">Safety Signals</div>
                <div class="stat-value">3</div>
                <div class="stat-detail">
                    <span class="stat-trend down">Under Investigation</span>
                    <span>DSMB review scheduled</span>
                </div>
            </div>
        </div>

        <!-- Content Section - Trial Cards -->
        <div class="content-grid">
            <div class="trial-card">
                <div class="trial-header">
                    <div class="trial-title">
                        <div class="trial-id">NCT04892156</div>
                        <h2 class="trial-name">Oncology Compound PC-427</h2>
                    </div>
                    <div class="trial-phase">Phase III</div>
                </div>

                <div class="trial-meta">
                    <div class="meta-item">
                        <div class="meta-label">Therapeutic Area</div>
                        <div class="meta-value">Solid Tumors</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Primary Endpoint</div>
                        <div class="meta-value">Overall Survival</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Target Enrollment</div>
                        <div class="meta-value">850 Patients</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Sites Active</div>
                        <div class="meta-value">127 Global</div>
                    </div>
                </div>

                <div class="progress-section">
                    <div class="progress-header">
                        <span class="progress-label">Patient Enrollment Progress</span>
                        <span class="progress-value">742 / 850 (87.3%)</span>
                    </div>
                    <div class="progress-bar">
                        <div class="progress-fill" style="width: 87.3%;"></div>
                    </div>
                </div>

                <div class="trial-status">
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>GCP Compliant</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>IRB Approved</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot info"></div>
                        <span>Data Lock: Q4 2025</span>
                    </div>
                </div>
            </div>

            <div class="trial-card">
                <div class="trial-header">
                    <div class="trial-title">
                        <div class="trial-id">NCT05123789</div>
                        <h2 class="trial-name">Cardiovascular Agent CV-892</h2>
                    </div>
                    <div class="trial-phase">Phase II</div>
                </div>

                <div class="trial-meta">
                    <div class="meta-item">
                        <div class="meta-label">Therapeutic Area</div>
                        <div class="meta-value">Heart Failure</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Primary Endpoint</div>
                        <div class="meta-value">NYHA Class Improvement</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Target Enrollment</div>
                        <div class="meta-value">420 Patients</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Sites Active</div>
                        <div class="meta-value">68 North America</div>
                    </div>
                </div>

                <div class="progress-section">
                    <div class="progress-header">
                        <span class="progress-label">Patient Enrollment Progress</span>
                        <span class="progress-value">387 / 420 (92.1%)</span>
                    </div>
                    <div class="progress-bar">
                        <div class="progress-fill" style="width: 92.1%;"></div>
                    </div>
                </div>

                <div class="trial-status">
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>GCP Compliant</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>IRB Approved</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot warning"></div>
                        <span>DSMB Review: Feb 2026</span>
                    </div>
                </div>
            </div>

            <div class="trial-card">
                <div class="trial-header">
                    <div class="trial-title">
                        <div class="trial-id">NCT05234012</div>
                        <h2 class="trial-name">Neurological Drug ND-341</h2>
                    </div>
                    <div class="trial-phase">Phase III</div>
                </div>

                <div class="trial-meta">
                    <div class="meta-item">
                        <div class="meta-label">Therapeutic Area</div>
                        <div class="meta-value">Alzheimer's Disease</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Primary Endpoint</div>
                        <div class="meta-value">CDR-SB Score</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Target Enrollment</div>
                        <div class="meta-value">1,200 Patients</div>
                    </div>
                    <div class="meta-item">
                        <div class="meta-label">Sites Active</div>
                        <div class="meta-value">214 Global</div>
                    </div>
                </div>

                <div class="progress-section">
                    <div class="progress-header">
                        <span class="progress-label">Patient Enrollment Progress</span>
                        <span class="progress-value">856 / 1,200 (71.3%)</span>
                    </div>
                    <div class="progress-bar">
                        <div class="progress-fill warning" style="width: 71.3%;"></div>
                    </div>
                </div>

                <div class="trial-status">
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>GCP Compliant</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot"></div>
                        <span>IRB Approved</span>
                    </div>
                    <div class="status-indicator">
                        <div class="status-dot info"></div>
                        <span>Interim Analysis: Q1 2026</span>
                    </div>
                </div>
            </div>
        </div>

        <!-- Data Table Section -->
        <div class="table-section">
            <div class="table-header">
                <h2 class="table-title">Pipeline Compound Analytics</h2>
                <div class="table-actions">
                    <button class="btn btn-secondary">Export Data</button>
                    <button class="btn btn-primary">Generate Report</button>
                </div>
            </div>

            <table class="data-table">
                <thead>
                    <tr>
                        <th>Compound</th>
                        <th>Development Phase</th>
                        <th>Trial Status</th>
                        <th>Enrolled Patients</th>
                        <th>Primary Efficacy</th>
                        <th>Safety Profile</th>
                        <th>Next Milestone</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>
                            <div class="compound-name">PC-427</div>
                            <div class="compound-id">CAS: 2847562-91-4</div>
                        </td>
                        <td><span class="phase-badge phase-3">Phase III</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot"></div>
                                <span class="status-label enrolled">Enrolled</span>
                            </div>
                        </td>
                        <td>742 / 850</td>
                        <td><span class="efficacy-value">HR: 0.68 (p<0.001)</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 94%;"></div>
                                </div>
                                <span>94/100</span>
                            </div>
                        </td>
                        <td>Database Lock: Nov 2025</td>
                    </tr>
                    <tr>
                        <td>
                            <div class="compound-name">CV-892</div>
                            <div class="compound-id">CAS: 2893471-65-2</div>
                        </td>
                        <td><span class="phase-badge phase-2">Phase II</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot"></div>
                                <span class="status-label enrolled">Enrolled</span>
                            </div>
                        </td>
                        <td>387 / 420</td>
                        <td><span class="efficacy-value">NYHA â†‘: 68% pts</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 91%;"></div>
                                </div>
                                <span>91/100</span>
                            </div>
                        </td>
                        <td>DSMB Review: Feb 2026</td>
                    </tr>
                    <tr>
                        <td>
                            <div class="compound-name">ND-341</div>
                            <div class="compound-id">CAS: 2901234-78-9</div>
                        </td>
                        <td><span class="phase-badge phase-3">Phase III</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot info"></div>
                                <span class="status-label recruiting">Recruiting</span>
                            </div>
                        </td>
                        <td>856 / 1,200</td>
                        <td><span class="efficacy-value">CDR-SB: -1.8 pts</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 88%;"></div>
                                </div>
                                <span>88/100</span>
                            </div>
                        </td>
                        <td>Interim Analysis: Q1 2026</td>
                    </tr>
                    <tr>
                        <td>
                            <div class="compound-name">IM-556</div>
                            <div class="compound-id">CAS: 2856734-42-1</div>
                        </td>
                        <td><span class="phase-badge phase-2">Phase II</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot info"></div>
                                <span class="status-label recruiting">Recruiting</span>
                            </div>
                        </td>
                        <td>124 / 280</td>
                        <td><span class="efficacy-value">ACR20: 58%</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 93%;"></div>
                                </div>
                                <span>93/100</span>
                            </div>
                        </td>
                        <td>Enrollment Complete: Q3 2026</td>
                    </tr>
                    <tr>
                        <td>
                            <div class="compound-name">OC-198</div>
                            <div class="compound-id">CAS: 2879123-55-6</div>
                        </td>
                        <td><span class="phase-badge phase-1">Phase I</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot"></div>
                                <span class="status-label enrolled">Enrolled</span>
                            </div>
                        </td>
                        <td>68 / 80</td>
                        <td><span class="efficacy-value">MTD: Established</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 96%;"></div>
                                </div>
                                <span>96/100</span>
                            </div>
                        </td>
                        <td>Phase II Planning: Q2 2026</td>
                    </tr>
                    <tr>
                        <td>
                            <div class="compound-name">RD-723</div>
                            <div class="compound-id">CAS: 2892456-33-8</div>
                        </td>
                        <td><span class="phase-badge phase-2">Phase II</span></td>
                        <td>
                            <div class="status-cell">
                                <div class="status-dot info"></div>
                                <span class="status-label recruiting">Recruiting</span>
                            </div>
                        </td>
                        <td>201 / 350</td>
                        <td><span class="efficacy-value">FEV1 â†‘: 210 mL</span></td>
                        <td>
                            <div class="safety-score">
                                <div class="safety-bar">
                                    <div class="safety-fill" style="width: 89%;"></div>
                                </div>
                                <span>89/100</span>
                            </div>
                        </td>
                        <td>6-Month Data: Aug 2026</td>
                    </tr>
                </tbody>
            </table>
        </div>
    </div>

    <!-- Footer -->
    <footer>
        <div class="footer-content">
            <div class="footer-section">
                <h3>Regulatory Compliance</h3>
                <ul>
                    <li>21 CFR Part 11 Validated System</li>
                    <li>ICH-GCP Guidelines Adherence</li>
                    <li>HIPAA Privacy Controls</li>
                    <li>EU GDPR Data Protection</li>
                    <li>ISO 14155:2020 Compliant</li>
                </ul>
            </div>

            <div class="footer-section">
                <h3>Data Integrity</h3>
                <ul>
                    <li>ALCOA+ Principles Applied</li>
                    <li>Electronic Audit Trail Enabled</li>
                    <li>Version Control: v4.2.1 (Build 20251209)</li>
                    <li>Last System Validation: Dec 2025</li>
                    <li>Next GxP Audit: Mar 2026</li>
                </ul>
            </div>

            <div class="footer-section">
                <h3>Quality Assurance</h3>
                <ul>
                    <li>SOP-compliant Workflows</li>
                    <li>CAPA System Integration</li>
                    <li>Deviation Management Active</li>
                    <li>Training Records Current</li>
                    <li>Risk-based Monitoring</li>
                </ul>
            </div>

            <div class="footer-section">
                <h3>System Information</h3>
                <p>
                    <strong>Environment:</strong> Production (Validated)<br>
                    <strong>Uptime:</strong> 99.97% (SLA: 99.9%)<br>
                    <strong>Last Backup:</strong> 2025-12-09 03:00 UTC<br>
                    <strong>Security:</strong> SOC 2 Type II Certified<br>
                    <strong>Support:</strong> gxp-support@pharmacorp.com
                </p>
            </div>

            <div class="compliance-footer">
                <p class="compliance-text">
                    This system is validated for use in regulated pharmaceutical research and development activities.
                    All data generated within this environment is subject to regulatory inspection and audit.
                    Unauthorized access or modification of clinical trial data may result in regulatory action and legal penalties.
                    For technical support or validation documentation, contact the Clinical Systems team.
                </p>
                <div class="compliance-badges">
                    <span class="compliance-icon">FDA 21 CFR Part 11</span>
                    <span class="compliance-icon">ICH-GCP E6(R2)</span>
                    <span class="compliance-icon">HIPAA Compliant</span>
                    <span class="compliance-icon">EU GDPR</span>
                    <span class="compliance-icon">ISO 14155:2020</span>
                    <span class="compliance-icon">SOC 2 Type II</span>
                </div>
            </div>
        </div>
    </footer>
</body>
</html>
